- Reaction score
- 940
Aclaris Therapeutics has just filed an Investigational New Drug application with the FDA for a new autoimmune-inhibiting oral treatment for Alopecia Universalis and Totalis. This application paves the way for human trials in 2017.
More information can be found in our Hair Loss News Center here: https://www.hairlosstalk.com/news/alopecia/aclaris-ati50001-areata-universalis-totalis-treatment/
Admin
More information can be found in our Hair Loss News Center here: https://www.hairlosstalk.com/news/alopecia/aclaris-ati50001-areata-universalis-totalis-treatment/
Admin